|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:approves
|
gptkb:1981
gptkb:FDA
|
|
gptkbp:average_temperature
|
room temperature
|
|
gptkbp:brand
|
Zovirax Cream
Zovirax Injection
Zovirax Tablets
|
|
gptkbp:category
|
Category B
|
|
gptkbp:clinical_trial
|
Phase II
Phase III
Phase I
|
|
gptkbp:contraindication
|
dehydration
renal impairment
hypersensitivity to acyclovir
|
|
gptkbp:dosage_form
|
400 mg
200 mg
800 mg
|
|
gptkbp:duration
|
10 days
5 days
7 days
long-term for chronic conditions
|
|
gptkbp:formulation
|
gptkb:tablet
gptkb:skincare_product
injection
|
|
gptkbp:frequency
|
once a day
3 times a day
5 times a day
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Zovirax
|
|
gptkbp:ingredients
|
gptkb:acyclovir
|
|
gptkbp:interacts_with
|
gptkb:mycophenolate_mofetil
gptkb:zidovudine
probenecid
other nephrotoxic agents
|
|
gptkbp:is_available_on
|
generic version
|
|
gptkbp:is_used_for
|
treating herpes simplex virus infections
treating varicella-zoster virus infections
|
|
gptkbp:manager
|
oral
intravenous
topical
|
|
gptkbp:manufacturer
|
gptkb:Glaxo_Smith_Kline
|
|
gptkbp:marketed_as
|
gptkb:legislation
gptkb:Australia
gptkb:United_Kingdom
gptkb:United_States
gptkb:Native_American_tribe
|
|
gptkbp:shelf_life
|
3 years
|
|
gptkbp:side_effect
|
dizziness
fatigue
headache
nausea
diarrhea
|
|
gptkbp:bfsParent
|
gptkb:acyclovir
|
|
gptkbp:bfsLayer
|
4
|